Cargando…

Simultaneous Screening of Nitrofuran Metabolites in Honey Using Biochip Array Technology: Validation Study According to the Decision 2002/657/EC of the European Union

BACKGROUND: Although no authorization is available for antibiotics to treat bee diseases, some veterinary compounds are used by beekeepers, and each country sets its own thresholds. Inappropriate and excessive use of these drugs can cause allergic reactions and antibiotic resistance in humans who co...

Descripción completa

Detalles Bibliográficos
Autores principales: Yazdanpanah, Hassan, Osouli, Mahraz, Salamzadeh, Jamshid, Karimi, Zakieh, Rashidi, Elham, Borhan, Ali, Yazdanpanah, Alireza, Eslamizad, Samira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Brieflands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024329/
https://www.ncbi.nlm.nih.gov/pubmed/36942071
http://dx.doi.org/10.5812/ijpr-129432
_version_ 1784909079611703296
author Yazdanpanah, Hassan
Osouli, Mahraz
Salamzadeh, Jamshid
Karimi, Zakieh
Rashidi, Elham
Borhan, Ali
Yazdanpanah, Alireza
Eslamizad, Samira
author_facet Yazdanpanah, Hassan
Osouli, Mahraz
Salamzadeh, Jamshid
Karimi, Zakieh
Rashidi, Elham
Borhan, Ali
Yazdanpanah, Alireza
Eslamizad, Samira
author_sort Yazdanpanah, Hassan
collection PubMed
description BACKGROUND: Although no authorization is available for antibiotics to treat bee diseases, some veterinary compounds are used by beekeepers, and each country sets its own thresholds. Inappropriate and excessive use of these drugs can cause allergic reactions and antibiotic resistance in humans who consume the remaining antibiotic residues in honey and its products. It is, therefore, relevant to monitor the presence of antibiotic residues in this matrix. OBJECTIVES: A rapid method for the simultaneous screening of nitrofuran metabolite residues in honey was validated according to Commission Decision 2002/657/EC (C.D 657) and the European guideline for the validation of screening methods for veterinary medicines. METHODS: This multi-analytical screening method enables the simultaneous determination of four nitrofuran metabolites [3-amino-2-oxazolidone (AOZ), 3-amino-5-morpholinomethyl-2-oxazolidinone (AMOZ), 1-Aminohydantoin HCl (ADH), and semicarbazide (SEC)] from a single honey sample. Thirty-five honey samples were collected randomly as real samples for screening from Tehran, IR Iran, Germany, and the Netherlands in 2018. RESULTS: For all four antibiotic residues, the positivity threshold T was higher than the cut-off value Fm, and no false-positive results were obtained for three antibiotics (AOZ, AMOZ, and SEC). Detection capabilities (CCβ) of all compounds were under the minimum required performance limit (MRPL) authorized by the European Commission (currently 1 μg/kg). The screening results of 15 domestic and 20 imported honey samples showed that the levels of AOZ in 6.66% and 10% of the samples, the level of AMOZ in 13.33% and 0% of the samples, and the level of SEC in 33.33% and 40% of the samples were less than the cut-off ([in relative light units (RLUs)], respectively. CONCLUSIONS: This study found that this technique is valid for detecting and quantifying three antibiotic residues in honey samples at the measured validation levels. This method was simple, rapid, and capable of simultaneously screening three nitrofuran metabolites from a single honey sample.
format Online
Article
Text
id pubmed-10024329
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Brieflands
record_format MEDLINE/PubMed
spelling pubmed-100243292023-03-19 Simultaneous Screening of Nitrofuran Metabolites in Honey Using Biochip Array Technology: Validation Study According to the Decision 2002/657/EC of the European Union Yazdanpanah, Hassan Osouli, Mahraz Salamzadeh, Jamshid Karimi, Zakieh Rashidi, Elham Borhan, Ali Yazdanpanah, Alireza Eslamizad, Samira Iran J Pharm Res Research Article BACKGROUND: Although no authorization is available for antibiotics to treat bee diseases, some veterinary compounds are used by beekeepers, and each country sets its own thresholds. Inappropriate and excessive use of these drugs can cause allergic reactions and antibiotic resistance in humans who consume the remaining antibiotic residues in honey and its products. It is, therefore, relevant to monitor the presence of antibiotic residues in this matrix. OBJECTIVES: A rapid method for the simultaneous screening of nitrofuran metabolite residues in honey was validated according to Commission Decision 2002/657/EC (C.D 657) and the European guideline for the validation of screening methods for veterinary medicines. METHODS: This multi-analytical screening method enables the simultaneous determination of four nitrofuran metabolites [3-amino-2-oxazolidone (AOZ), 3-amino-5-morpholinomethyl-2-oxazolidinone (AMOZ), 1-Aminohydantoin HCl (ADH), and semicarbazide (SEC)] from a single honey sample. Thirty-five honey samples were collected randomly as real samples for screening from Tehran, IR Iran, Germany, and the Netherlands in 2018. RESULTS: For all four antibiotic residues, the positivity threshold T was higher than the cut-off value Fm, and no false-positive results were obtained for three antibiotics (AOZ, AMOZ, and SEC). Detection capabilities (CCβ) of all compounds were under the minimum required performance limit (MRPL) authorized by the European Commission (currently 1 μg/kg). The screening results of 15 domestic and 20 imported honey samples showed that the levels of AOZ in 6.66% and 10% of the samples, the level of AMOZ in 13.33% and 0% of the samples, and the level of SEC in 33.33% and 40% of the samples were less than the cut-off ([in relative light units (RLUs)], respectively. CONCLUSIONS: This study found that this technique is valid for detecting and quantifying three antibiotic residues in honey samples at the measured validation levels. This method was simple, rapid, and capable of simultaneously screening three nitrofuran metabolites from a single honey sample. Brieflands 2022-11-22 /pmc/articles/PMC10024329/ /pubmed/36942071 http://dx.doi.org/10.5812/ijpr-129432 Text en Copyright © 2022, Author(s) https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Yazdanpanah, Hassan
Osouli, Mahraz
Salamzadeh, Jamshid
Karimi, Zakieh
Rashidi, Elham
Borhan, Ali
Yazdanpanah, Alireza
Eslamizad, Samira
Simultaneous Screening of Nitrofuran Metabolites in Honey Using Biochip Array Technology: Validation Study According to the Decision 2002/657/EC of the European Union
title Simultaneous Screening of Nitrofuran Metabolites in Honey Using Biochip Array Technology: Validation Study According to the Decision 2002/657/EC of the European Union
title_full Simultaneous Screening of Nitrofuran Metabolites in Honey Using Biochip Array Technology: Validation Study According to the Decision 2002/657/EC of the European Union
title_fullStr Simultaneous Screening of Nitrofuran Metabolites in Honey Using Biochip Array Technology: Validation Study According to the Decision 2002/657/EC of the European Union
title_full_unstemmed Simultaneous Screening of Nitrofuran Metabolites in Honey Using Biochip Array Technology: Validation Study According to the Decision 2002/657/EC of the European Union
title_short Simultaneous Screening of Nitrofuran Metabolites in Honey Using Biochip Array Technology: Validation Study According to the Decision 2002/657/EC of the European Union
title_sort simultaneous screening of nitrofuran metabolites in honey using biochip array technology: validation study according to the decision 2002/657/ec of the european union
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024329/
https://www.ncbi.nlm.nih.gov/pubmed/36942071
http://dx.doi.org/10.5812/ijpr-129432
work_keys_str_mv AT yazdanpanahhassan simultaneousscreeningofnitrofuranmetabolitesinhoneyusingbiochiparraytechnologyvalidationstudyaccordingtothedecision2002657ecoftheeuropeanunion
AT osoulimahraz simultaneousscreeningofnitrofuranmetabolitesinhoneyusingbiochiparraytechnologyvalidationstudyaccordingtothedecision2002657ecoftheeuropeanunion
AT salamzadehjamshid simultaneousscreeningofnitrofuranmetabolitesinhoneyusingbiochiparraytechnologyvalidationstudyaccordingtothedecision2002657ecoftheeuropeanunion
AT karimizakieh simultaneousscreeningofnitrofuranmetabolitesinhoneyusingbiochiparraytechnologyvalidationstudyaccordingtothedecision2002657ecoftheeuropeanunion
AT rashidielham simultaneousscreeningofnitrofuranmetabolitesinhoneyusingbiochiparraytechnologyvalidationstudyaccordingtothedecision2002657ecoftheeuropeanunion
AT borhanali simultaneousscreeningofnitrofuranmetabolitesinhoneyusingbiochiparraytechnologyvalidationstudyaccordingtothedecision2002657ecoftheeuropeanunion
AT yazdanpanahalireza simultaneousscreeningofnitrofuranmetabolitesinhoneyusingbiochiparraytechnologyvalidationstudyaccordingtothedecision2002657ecoftheeuropeanunion
AT eslamizadsamira simultaneousscreeningofnitrofuranmetabolitesinhoneyusingbiochiparraytechnologyvalidationstudyaccordingtothedecision2002657ecoftheeuropeanunion